ASA Clears RB Of Misleading UK Consumers In Two Nurofen Ads
Executive Summary
The UK's Advertising Standards Authority has cleared Reckitt Benckiser of misleading British consumers with two advertisements for its Nurofen brand of analgesics.
You may also be interested in...
Comparison Claims Must Be Verifiable, UK Ad Regulator Warns Reckitt
Failure to give consumers opportunity to verify claims made in an ad for its Lemsip cold and flu brand has landed Reckitt Benckiser in hot water with the UK Advertising Standards Authority.
Ouch! Two UK Analgesic Ad Complaints: Reckitt Rapped, Perrigo Pardoned
Two UK advertising complaint verdicts delivered by the MHRA, Reckitt Benckiser's Nurofen Express (upheld) and Perrigo's Solpadeine Max (not upheld).
Reckitt Benckiser Exploring AI With Help Of Israeli Start-Ups
RB is looking to work with Israeli start-ups that can utilize emerging digital technologies to provide 'real world' consumer healthcare solutions.